2023 Clinical Trials Grant (osteosarcoma)
The Clinical Trials Grant from the Osteosarcoma Institute supports researchers worldwide planning to conduct clinical trials in osteosarcoma. The proposed trial may be conducted at a single institution, a clinical trial consortium, or through an existing clinical trial infrastructure. The results of the proposed trial should be expected within 3 years. Applicants may apply for up to 800,000 USD. Letters of intent are due on November 15, 2022. Invited full applications are due on April 14, 2023.
Create or log-in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.